A new publication involving icatibant was published on August 14, 2026. The article, titled "Pediatric hereditary angioedema presenting as recurrent episodic abdominal pain and vomiting: Challenges in diagnosis and management," appears in JPGN Reports.
The publication is listed under PubMed ID 42602212. It is categorized as a case-based publication addressing diagnostic and management challenges related to pediatric hereditary angioedema.
No specific findings, outcomes, or efficacy data from the publication have been provided in this report. The event data confirms only the title, journal, and publication date.
Readers interested in learning more about icatibant, including its approved regulatory status, can refer to the compound overview for additional context.